These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia. Zhang X; Li G; Wei X; Mo X; Hu L; Zha Y; Hou J J Urol; 2012 Sep; 188(3):881-7. PubMed ID: 22819411 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness--new standards for noninvasive bladder outlet obstruction diagnosis? Franco G; De Nunzio C; Leonardo C; Tubaro A; Ciccariello M; De Dominicis C; Miano L; Laurenti C J Urol; 2010 Jun; 183(6):2270-4. PubMed ID: 20400138 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352 [TBL] [Abstract][Full Text] [Related]
6. Comparison of MR imaging and urodynamic findings in benign prostatic hyperplasia. Alam AM; Sugimura K; Okizuka H; Ishida J; Igawa M Radiat Med; 2000; 18(2):123-8. PubMed ID: 10888045 [TBL] [Abstract][Full Text] [Related]
7. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)]. Gabuev A; Oelke M Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia. van Venrooij GE; Eckhardt MD; Boon TA Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441 [TBL] [Abstract][Full Text] [Related]
9. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657 [TBL] [Abstract][Full Text] [Related]
10. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms. Mehdizadeh JL; Leach GE Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043 [TBL] [Abstract][Full Text] [Related]
12. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation. Blaivas JG Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781 [TBL] [Abstract][Full Text] [Related]
13. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847 [TBL] [Abstract][Full Text] [Related]
14. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619 [TBL] [Abstract][Full Text] [Related]
15. Manual versus computer methods for diagnosing obstruction from pressure-flow tracings in patients with benign prostatic hyperplasia. Trucchi A; Franco G; Manieri C; Valenti M; Carter SS; Tubaro A J Urol; 1997 Mar; 157(3):871-5. PubMed ID: 9072589 [TBL] [Abstract][Full Text] [Related]
16. Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptoms. Chung DE; Lee RK; Kaplan SA; Te AE J Urol; 2010 Dec; 184(6):2434-9. PubMed ID: 20952031 [TBL] [Abstract][Full Text] [Related]
17. The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction. Groutz A; Blaivas JG; Fait G; Sassone AM; Chaikin DC; Gordon D J Urol; 2000 Jan; 163(1):207-11. PubMed ID: 10604349 [TBL] [Abstract][Full Text] [Related]
18. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. Parsons JK J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143 [TBL] [Abstract][Full Text] [Related]
19. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry. Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG; J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia]. Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]